# Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia

> **NCT01598896** · PHASE2,PHASE3 · TERMINATED · sponsor: **Mclean Hospital** · enrollment: 12 (actual)

## Conditions studied

- Cannabis Dependence
- Marijuana Dependence

## Interventions

- **DRUG:** Dronabinol
- **DRUG:** Clonidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01598896
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-05
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** low enrollment due to limited resources
- **Last updated:** 2018-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01598896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01598896, "Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01598896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*